---
schema_version: "secwatch.filing_event.v1"
accession: "0000105770-25-000043"
form_type: "8-K/A"
ticker: "WST"
cik: "0000105770"
company_name: "WEST PHARMACEUTICAL SERVICES INC"
filed_at: "2025-05-12T23:59:59+00:00"
generated_at: "2026-05-21T22:49:57.093468+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# West Pharma shareholders approve amended 2016 Omnibus Plan; share reserve increased by 2M

## Summary
- Shareholders approved amendment effective May 6, 2025; total share reserve increased to 7,500,000 from 5,500,000.
- Full value awards granted on/after May 6, 2025 count as 2.0 shares vs. 2.5 previously, reducing per-award dilution.
- Most awards subject to minimum 12-month vesting; up to 5% of shares exempt from this requirement.
- Non-employee director annual compensation cap raised to $800,000 (including cash).
- Plan term extended to May 6, 2035; awards outstanding upon termination remain in effect.

## SEC filing metadata
- accession: 0000105770-25-000043
- form_type: 8-K/A
- ticker: WST
- cik: 0000105770
- company_name: WEST PHARMACEUTICAL SERVICES INC
- filed_at: 2025-05-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/105770/000010577025000043/0000105770-25-000043-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/105770/000010577025000043/wst-20250506.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000105770-25-000043
- JSON: https://secwatch.observer/filing/0000105770-25-000043.json
- Plain text: https://secwatch.observer/filing/0000105770-25-000043.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.